AI-Pharma.Capital Fund

Specialized Hybrid Investment Fund for the AI in Pharma Industry

 

about us

AI-Pharma is a hybrid investment fund specifically focused on the AI in Pharma and Drug Discovery sector, backed by seasoned professionals who have been active in both the investment banking and AI for Drug Discovery industries for years, long before the sector was recognized as a serious prospect by the overwhelming majority of investors, and some of whom made their first investments into the sector in 2014. The fund structures its portfolio based on sophisticated industry intelligence and comparative analytics provided by the Pharma Division of Deep Knowledge Analytics, the world-leading source of market intelligence on the AI for Drug Discovery, Biomarker Discovery and Advanced R&D sector, and which uses hundreds of quantitative and fact-based parameters to identify prospective investment targets for the fund, utilizing multidimensional analytical frameworks as complex as the industry itself.

AI for Drug Discovery, Biomarker Development and Advanced R&D is considered by the majority of experts and analysts as one of the most prospective sectors in the Pharma industry, with the greatest disruptive potential and capability to increase the efficiency and decrease the cost of developing new drugs, and to improve the performance and profitability of leading Pharma corporations.

 

Provides Liquidity Similar to Hedge Funds Combined With Venture Fund Style Objectives

Invests in the Top 10% of Companies in the Longevity Industry

Significantly De-Risks the Interests of Limited Partners and Portfolio

Bets on the Success of the Entire Industry, rather than  of Individual Companies

 

OUR TEAM

DMITRY KAMINSKIY

GENERAL PARTNER

Dmitry Kaminskiy, based in London. He is an experienced AI in Pharma industry investor and entrepreneur, founder of Deep Knowledge Ventures and Aging Analytics Agency since 2014.

  • LinkedIn Social Icon

MARGARETTA COLANGELO

MANAGING PARTNER

Margaretta Colangelo, based in San Francisco, has 30+ years experience in executive, founder and advisory positions in the IT-industry.

  • LinkedIn Social Icon

STEFAN HASCOET

MANAGING PARTNER

Stefan Hascoet, based in Geneva, is the Capital Markets Professional with 15 years experience in investment products, derivatives and non-recourse lending facilities.

  • LinkedIn Social Icon

KATE BATZ

MANAGING PARTNER

Kate Batz, based in San Francisco, is licensed to practice law in California and New York. Lawyer with 20 years experience as a Corporate Attorney

  • LinkedIn Social Icon
 

CONTACT US

Contact Form
Subscribe to Our News